Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

Chief Executive Officer

Chief Scientific Officer

Chief Operating Officer

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical need in the United States. The company's lead protein therapeutic product candidate KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in patients with myelofibrosis. It also develops KER-047, a small molecule product candidate that is in Phase II clinical trials for the treatment of functional iron deficiency; and KER-012, which is in Phase II clinical trials to treat pulmonary arterial hypertension and cardiovascular disorders. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes novel treatments for patient...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-11-04	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-11-04	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-06-09	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-06-09	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-06-08	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-06-08	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-04-08	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-11-29	Premium	sold	Premium	Premium	Premium	-
2022-11-29	Premium	sold	Premium	Premium	Premium	-
2022-11-29	Premium	sold	Premium	Premium	Premium	-
2022-07-15	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-07-15	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2022-07-13	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2022-07-13	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-06-14	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-06-09	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-05-11	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-05-11	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2022-04-11	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2022-04-11	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-04-06	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2022-04-06	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2022-04-04	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2022-04-04	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2022-04-01	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer

KROS - Keros Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for KROS